Sugi Predict

Sugi Predict / Compounds / SCHEMBL234997

SCHEMBL234997

SCHEMBL234997

CCOC(=O)CC(CC(=O)OCC)CC(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGAM O43451 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ SI P14410 1/20 0.46
▸ MGAM2 Q2M2H8 1/20 0.46
▸ ALDH1A1 P00352 6/20 0.43
▸ TRPA1 O75762 1/20 0.43
▸ CACNA2D1 P54289 2/20 0.41
▸ CACNB3 P54284 1/20 0.41
▸ CACNA1C Q13936 1/20 0.41
▸ PGR P06401 1/20 0.41
▸ ADRA1A P35348 1/20 0.41
▸ HTR2B P41595 1/20 0.41
▸ CACNA2D2 Q9NY47 1/20 0.41
▸ ALOX15 P16050 3/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ HSD17B10 Q99714 2/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ ADORA1 P30542 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3291696 0.92 CACNA2D1 (0.53) MGAMGAASIMGAM2ALDH1A1
SCHEMBL15969817 0.92 CACNA2D1 (0.53) MGAMGAASIMGAM2ALDH1A1
SCHEMBL3291702 0.92 CACNA2D1 (0.53) MGAMGAASIMGAM2ALDH1A1
SCHEMBL27539220 0.92 MGAM (0.43) MGAMGAASIMGAM2ALDH1A1
SCHEMBL4329152 0.91 CACNA2D1 (0.39) MGAMGAASIMGAM2ALDH1A1
SCHEMBL21589071 0.91 CACNA2D1 (0.39) MGAMGAASIMGAM2ALDH1A1
SCHEMBL27857355 0.91 CACNA2D1 (0.39) MGAMGAASIMGAM2ALDH1A1
SCHEMBL8057583 0.90 MGAM (0.41) MGAMGAASIMGAM2ALDH1A1
SCHEMBL16317237 0.88 ALDH1A1 (0.47) MGAMGAASIMGAM2ALDH1A1
SCHEMBL8347689 0.88 MGAM (0.40) MGAMGAASIMGAM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116694694-A Enzyme catalysis process for preparing pregabalin chiral intermediate 尚科生物医药（上海）有限公司 2023-09-05 — — CN claimed
CN-112301017-A Lipase derived from pseudomonas and application thereof 江苏美科生物科技有限公司 2021-02-02 — — CN claimed
CN-113564144-B Lipase mutant and application thereof 上海奥博生物医药股份有限公司 2025-04-04 — — CN disclosed
CN-118956817-A Lipase mutant and application thereof 上海奥博生物医药股份有限公司 2024-11-15 — — CN disclosed
CN-113179643-B Catalyst component for olefin polymerization 巴塞尔聚烯烃意大利有限公司 2024-07-05 — — CN disclosed
CN-112048492-B Ester hydrolase mutant 尚科生物医药（上海）有限公司 2023-12-22 — — CN disclosed
CN-116694694-A Enzyme catalysis process for preparing pregabalin chiral intermediate 尚科生物医药（上海）有限公司 2023-09-05 — — CN disclosed
CN-116694694-A Enzyme catalysis process for preparing pregabalin chiral intermediate 尚科生物医药（上海）有限公司 2023-09-05 — — CN disclosed
CN-218854307-U Reaction device for processing 3-isobutyl glutaric acid 太仓市茜泾化工有限公司 2023-04-14 — — CN disclosed
US-20220081497-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2022-03-17 — — US disclosed
EP-3908614-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS Basell Poliolefine Italia S.r.l. (IT) 2021-11-17 — — EP disclosed
US-8426537-B2 Solid catalyst component and catalyst for polymerization of olefins, and process for production of olefin polymers using same TOHO TITANIUM CO., LTD. (JP) 2013-04-23 — — US disclosed
US-20120004378-A1 SOLID CATALYST COMPONENT AND CATALYST FOR POLYMERIZATION OF OLEFINS, AND PROCESS FOR PRODUCTION OF OLEFIN POLYMERS USING SAME TOHO TITANIUM CO., LTD (JP) 2012-01-05 — — US disclosed
EP-2360190-A1 SOLID CATALYST COMPONENT AND CATALYST FOR POLYMERIZATION OF OLEFINS, AND PROCESS FOR PRODUCTION OF OLEFIN POLYMERS USING SAME Toho Titanium CO., LTD. (JP) 2011-08-24 — — EP disclosed
US-20080311635-A1 PROCESS FOR THE PREPARATION OF (S)(+)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID DIPHARMA FRANCIS S.R.L. (IT) 2008-12-18 — — US disclosed
EP-1992609-A1 A process for the preparation of a (S)(+)-3-(aminomethyl)-5-methylhexanoic acid Dipharma Francis S.r.l. (IT) 2008-11-19 — — EP disclosed
EP-1082359-B1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE SRL (IT) 2006-07-19 — — EP disclosed
US-6541582-B1 Catalytic polymerization of propylene via magnesium chloride, titanium chloride, and beta-substituted glutarates; stereospecificity; high isotactic index expressed in terms of high xylene insolubility BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2003-04-01 — — US disclosed
EP-1082359-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS Basell Technology Company B.V. (NL) 2001-03-14 — — EP disclosed
WO-2000055215-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL TECHNOLOGY COMPANY B.V. (NL) 2000-09-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080311635-A1 PROCESS FOR THE PREPARATION OF (S)(+)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID ADH5, ALDH7A1, ADH1C MGAM 740/4885GAA 1024/4885SI 185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.